x
Filter:
Filters applied
- Congenital: Fontan
- PLERemove PLE filter
Publication Date
Please choose a date range between 2020 and 2022.
Author
- D'Udekem, Yves2
- Iyengar, Ajay J2
- Alphonso, Nelson1
- Betts, Kim S1
- Bullock, Andrew1
- Burchill, Luke1
- Burri, Melchior1
- Celermajer, David S1
- Cleuziou, Julie1
- Cordina, Rachael1
- Du Plessis, Karin1
- Ewert, Peter1
- Gentles, Thomas1
- Hager, Alfred1
- Heinisch, Paul Philipp1
- Hörer, Jürgen1
- Justo, Robert1
- Justo, Robert N1
- Kido, Takashi1
- Marathe, Supreet P1
- Ono, Masamichi1
- Ruf, Bettina1
- Salve, Gananjay G1
- Sharma, Varun J1
- Stern, Christoph1
Keyword
- CI3
- confidence interval3
- BCPS2
- bidirectional cavopulmonary shunt2
- hazard ratio2
- HLHS2
- HR2
- hypoplastic left heart syndrome2
- interquartile range2
- IQR2
- protein losing enteropathy2
- protein-losing enteropathy2
- ANZFR1
- Australia and New Zealand Fontan Registry1
- AV1
- AVV1
- DORV1
- Fontan1
- Fontan failure1
- Fontan palliation1
- Fontan takedown1
- ICU1
- New York Heart Association1
- NYHA1
Congenital: Fontan
3 Results
- Congenital: Fontan
The impact of pulmonary artery size on midterm outcomes after nonfenestrated Fontan operation
The Journal of Thoracic and Cardiovascular SurgeryVol. 165Issue 5p1651–1660.e2Published online: September 5, 2022- Takashi Kido
- Christoph Stern
- Paul Philipp Heinisch
- Melchior Burri
- Janez Vodiskar
- Martina Strbad
- and others
Cited in Scopus: 0We sought to identify the impact of pulmonary artery size on outcomes after nonfenestrated total cavopulmonary connection. In a subgroup of patients with right-sided bidirectional cavopulmonary shunt, the impact of each branch pulmonary artery size was individually determined. - Congenital: FontanOpen Archive
Long-term outcomes following Fontan takedown in Australia and New Zealand
The Journal of Thoracic and Cardiovascular SurgeryVol. 161Issue 3p1126–1135Published online: October 5, 2020- Supreet P. Marathe
- Ajay J. Iyengar
- Kim S. Betts
- Karin du Plessis
- Gananjay G. Salve
- Robert N. Justo
- and others
Cited in Scopus: 3Fontan takedown remains an option for the management of Fontan failure. We sought to evaluate early and late outcomes after Fontan takedown. - Congenital: Fontan
Protein-losing enteropathy and plastic bronchitis after the Fontan procedure
The Journal of Thoracic and Cardiovascular SurgeryVol. 161Issue 6p2158–2165.e4Published online: August 11, 2020- Varun J. Sharma
- Ajay J. Iyengar
- Diana Zannino
- Thomas Gentles
- Robert Justo
- David S. Celermajer
- and others
Cited in Scopus: 15Protein losing enteropathy and plastic bronchitis are severe complications in Fontan circulation, with 5-year survival ranging from 46% to 88%. We report risk factors and outcomes of protein losing enteropathy and plastic bronchitis in patients undergoing the Fontan.